Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Schwann cells respond to cyclic adenosine monophosphate (cAMP) halting proliferation and expressing myelin proteins. Here we show that cAMP signaling induces the nuclear shuttling of the class IIa histone deacetylase (HDAC)-4 in these cells, where it binds to the promoter and blocks the expression of
c-Jun
, a negative regulator of myelination. To do it, HDAC4 does not interfere with the transcriptional activity of
MEF2
. Instead, by interacting with NCoR1, it recruits HDAC3 and deacetylates histone 3 in the promoter of
c-Jun
, blocking gene expression. Importantly, this is enough to up-regulate
Krox20
and start Schwann cell differentiation program-inducing myelin gene expression. Using conditional knockout mice, we also show that HDAC4 together with HDAC5 redundantly contribute to activate the myelin transcriptional program and the development of myelin sheath in vivo. We propose a model in which cAMP signaling shuttles class IIa HDACs into the nucleus of Schwann cells to regulate the initial steps of myelination in the peripheral nervous system.
...
PMID:Class IIa histone deacetylases link cAMP signaling to the myelin transcriptional program of Schwann cells. 2947 87
<< Previous
1
2